Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
11.
Am J Obstet Gynecol ; 98(3): 411-3, 1967 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-5630224

RESUMEN

PIP: In an investigation of the excretion of oral contraceptives in the milk of lactating women, tritiated norethynodrel (the progestin component of Enovid) was administered after 2 days of Enovid to 4 patients with stillbirths. An average of 1.1% (range .45-1.52%) of the radioactive norethynodrel was excreted in the breast milk; on the basis of 5.0 mg of norethynodrel per Enovid tablet this amounts to an excretion of 55 mg of the progestin and its metabolites. Since such products could affect the infant, caution is urged in administration of oral contraceptives during lactation.^ieng


Asunto(s)
Anticonceptivos Orales/metabolismo , Lactancia , Leche Humana , Noretinodrel/metabolismo , Administración Oral , Adulto , Anticonceptivos Orales/farmacología , Femenino , Humanos , Recién Nacido , Leche Humana/metabolismo , Noretinodrel/farmacología , Embarazo , Tritio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA